Revitalizing lives, one spine at a time

The first regenerative fetal-inspired biomaterial to treat Low Back Pain (LBP) through a minimally invasive application.

The problem

Low back pain affects up to 85% of the people, ranking first in terms of years lived with disability.

150 billion € spent every year
150 million sick leave days lost
36,4% rise expected by 2050

The solution

Our solution can be injected into the patients’ spine either at early or late stages of degeneration, allowing for a full regenerative and long-term effect.

The benefits

Efficient, safe, and sustainable technology for better healthcare solutions

Full regenerative and long-term effect with a single injection
No need for risky surgeries and reoperations
Shortens intervention
time by 90%
Reduces hospitalization
stays by 70%
Promotes circular economy by using animal waste
Leads to significant
healthcare savings
Restores patients’ long active lives

Driving success

With years of expertise, prestigious awards, groundbreaking research, and key partnerships, we’ve built a catalyst for progress in the biotech space. The funding attracted has been cornerstone in positioning us to revolutionize healthcare.

10+

Years of study

5

Articles Published

~1M

Capital Raised

Funded by
Funded by the European Union. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the European Innovation Councial. Neither the European Union nor the granting authority can be held responsible for them.
Our Trusted Partners
‍

The opinion of experts

“This new treatment could potentially alter […] ageing, both in the terms of prevention […] but also reversing the biological condition, […] getting a spine that would be more functional with a minimally invasive procedure”
Nuno Neves (Orthopaedic Spine Surgeon) - Advisory Board Member
"We really need to find new solutions to an old problem [...] a more functional way of treating the disease"
Paulo Pereira (Neurosurgeon) - Advisory Board Member
"These animals [...] have a lot of pain and this will be [...] a new opportunity for them"
Irina Amorim (Doctor in Veterinary Medicine) - Member of Advisory Board
"[Current treatments] will ease the symptoms, but won't resolve the situation [...] an alternative treatment is more than welcome"
Flávia Rocha (Doctor in Veterinary Medicine)

On the spotlight

Follow us on LinkedIn or subscribe to receive our news content

Fetalix engages the community at the European Researcher’s Night

Public engagement plays an important role in bridging the gap between scientific research and society. By creating opportunities for dialogue, researchers can share their work, inspire curiosity, and better understand the perspectives and needs of the communities they aim to serve.

Fetalix and the UN Sustainable Development Goals

The United Nations Sustainable Development Goals (SDGs) provide a global framework for addressing some of the world's most pressing social, economic, and environmental challenges. Science, research, and innovation play a key role in achieving these objectives by driving the development of solutions that improve lives while supporting a more sustainable future.

Fetalix showcases at Al Andalus Innovation Ventures

Innovation-focused events provide valuable opportunities for startups, investors, researchers, and industry leaders to connect, exchange ideas, and explore solutions to pressing societal challenges. For emerging biotechnology companies, these gatherings play an important role in fostering collaboration, increasing visibility, and creating pathways for growth.

Take part in the healthcare revolution!
Join our mission to transform spinal health improving the lives of millions of people
Contact us